Immunome Inc. (IMNM)
NASDAQ: IMNM
· Real-Time Price · USD
7.86
-0.05 (-0.63%)
At close: May 14, 2025, 3:01 PM
Immunome Revenue
Immunome reported an annual revenue of $9.04M, reflecting a -35.5% growth. For the quarter ending March 31, 2025, Immunome generated $2.93M in revenue.
Revenue (ttm)
$9.04M
Revenue Growth
-35.5%
Price / Sales Ratio
68.88
Revenue / Employee
$76.62K
Employees
118
Market Cap
683.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|